New COVID-19 drug to be trialled in UK hospitals

UK hospitals are trialling a new drug, TRV027, that aims to restore the balance between the two hormones, angiotensin II and angiotensin 1-7, to help prevent blood clots and lung damage caused by COVID-19.Science Focus
Source: Society for Endocrinology - Category: Endocrinology Source Type: news